Article
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
2021-10-01
Abstract excerpt
Understanding of the molecular mechanisms of prostate cancer has led to development of therapeutic strategies targeting androgen receptor (AR). These androgen-receptor signaling inhibitors (ARSI) include androgen synthesis inhibitor- abiraterone and androgen receptor antagonists- enzalutamide, apalutamide, and darolutamide. Although these medications provide significant improvement in survival among men with prost...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af1f9feb-c297-5917-99d6-aead9898731d
- DOI
- 10.20944/preprints202110.0016.v1
